2014

1. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): Follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

   The Lancet Oncology, Vol. 15, Núm. 6, pp. 640-647